IXHL
Incannex Healthcare
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
IXHL Profile
Incannex Healthcare Inc.
A company that develops combinations of synthetic cannabinoids and psychedelic agents
Suite 105, 8 Century Circuit Norwest, NSW 2153, Australia
--
Incannex Healthcare Inc., is incorporated in Delaware. Incannex Healthcare Inc., a clinical-stage drug development company, is developing unique medicinal cannabis drug products and psychedelic drug therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain injury (TBI) and concussion, pulmonary inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety, addiction disorder and pain, among other indications.